Article info

Original research
Autoimmune retinopathy with associated anti-retinal antibodies as a potential immune-related adverse event associated with immunotherapy in patients with advanced cutaneous melanoma: case series and systematic review

Authors

  1. Correspondence to Dr Renelle Pointdujour-Lim; Renelle.lim{at}yale.edu
View Full Text

Citation

Heng JS, Kim JM, Jones DK, et al
Autoimmune retinopathy with associated anti-retinal antibodies as a potential immune-related adverse event associated with immunotherapy in patients with advanced cutaneous melanoma: case series and systematic review

Publication history

  • Received August 31, 2021
  • Accepted December 4, 2021
  • First published January 3, 2022.
Online issue publication 
January 03, 2022
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.